{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:31:31Z","timestamp":1790962291499,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K17423"],"award-info":[{"award-number":["JP20K17423"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K16357"],"award-info":[{"award-number":["JP22K16357"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.jaut.2023.103131","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T12:54:26Z","timestamp":1699102466000},"page":"103131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFN\u03b3 in myositis"],"prefix":"10.1016","volume":"142","author":[{"given":"Hirokazu","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuka","family":"Umezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Itakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Iwai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6171-2077","authenticated-orcid":false,"given":"Shinsuke","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103131_bib1","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"European League against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103131_bib2","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/14397595.2018.1467257","article-title":"Current diagnosis and treatment of polymyositis and dermatomyositis","volume":"28","author":"Sasaki","year":"2018","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jaut.2023.103131_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/intimm\/8.5.765","article-title":"Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes","volume":"8","author":"Agata","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd2712","article-title":"Revisiting the PD-1 pathway","volume":"6","author":"Patsoukis","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jaut.2023.103131_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102586","article-title":"Immune checkpoint inhibitor-induced myositis, the earliest and most lethal complication among rheumatic and musculoskeletal toxicities","volume":"19","author":"Allenbach","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2023.103131_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803410","article-title":"Incidence and Distinct Features of immune checkpoint inhibitor-related myositis from idiopathic inflammatory myositis: a single-center experience with systematic literature review and meta-analysis","volume":"12","author":"Hamada","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-002890","article-title":"Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors","volume":"9","author":"Guidon","year":"2021","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jaut.2023.103131_bib8","doi-asserted-by":"crossref","first-page":"e558","DOI":"10.1212\/NXI.0000000000000558","article-title":"PD1 pathway in immune-mediated myopathies: pathogenesis of dysfunctional T cells revisited","volume":"6","author":"Knauss","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jaut.2023.103131_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1084\/jem.20022125","article-title":"The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"198","author":"Ansari","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2023.103131_bib10","doi-asserted-by":"crossref","first-page":"10691","DOI":"10.1073\/pnas.0307252101","article-title":"PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells","volume":"101","author":"Latchman","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2023.103131_bib11","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1084\/jem.20022119","article-title":"Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis","volume":"198","author":"Salama","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jaut.2023.103131_bib12","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.4049\/jimmunol.176.6.3480","article-title":"Differential role of programmed death-ligand 1 and programmed death-ligand 2 in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis","volume":"176","author":"Zhu","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib13","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1002\/eji.200324228","article-title":"Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responses","volume":"33","author":"Liang","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-065X.2012.01136.x","article-title":"Immune checkpoints in central nervous system autoimmunity","volume":"248","author":"Joller","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2023.103131_bib15","first-page":"1529","article-title":"Dual biological effects of the cytokines interleukin-10 and interferon-\u03b3, Cancer Immunology","volume":"60","author":"Wilke","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaut.2023.103131_bib16","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-16-0224","article-title":"Dual faces of ifn\u03b3 in cancer progression: a role of pd-l1 induction in the determination of proand antitumor immunity","volume":"22","author":"Mandai","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jaut.2023.103131_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-18570-x","article-title":"PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jaut.2023.103131_bib18","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.3389\/fimmu.2021.648946","article-title":"IFN\u03b3, and to a lesser extent TNF\u03b1, provokes a sustained endothelial costimulatory phenotype","volume":"12","author":"Valenzuela","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110400","article-title":"IFN\u03b3-induced PD-L1 expression in ovarian cancer cells is regulated by JAK1, STAT1 and IRF1 signaling","volume":"97","author":"Padmanabhan","year":"2022","journal-title":"Cell. Signal."},{"key":"10.1016\/j.jaut.2023.103131_bib20","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/cas.15442","article-title":"Classification of PD\u2010L1 expression in various cancers and macrophages based on immunohistocytological analysis","volume":"113","author":"Saito","year":"2022","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jaut.2023.103131_bib21","first-page":"891","article-title":"Sustained low-level expression of interferon-\u03b3 promotes tumor development: potential insights in tumor prevention and tumor immunotherapy, Cancer Immunology","volume":"54","author":"He","year":"2005","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaut.2023.103131_bib22","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/0008-5472.CAN-03-3259","article-title":"PD-L1\/B7H-1 inhibits the effector phase of tumor rejection by T cell receptor (TCR) transgenic CD8+ T cells","volume":"64","author":"Blank","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.jaut.2023.103131_bib23","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.39592","article-title":"Interferon-\u03b3, but not interleukin-4, suppresses experimental polymyositis","volume":"68","author":"Yoshihashi-Nakazato","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103131_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","article-title":"Restoring function in exhausted CD8 T cells during chronic viral infection","volume":"439","author":"Barber","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2023.103131_bib25","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","article-title":"Molecular signature of CD8+ T cell exhaustion during chronic viral infection","volume":"27","author":"Wherry","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2023.103131_bib26","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2023.103131_bib27","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1182\/blood-2006-09-044826","article-title":"PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors","volume":"109","author":"Zhang","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jaut.2023.103131_bib28","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/nm1482","article-title":"Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction","volume":"12","author":"Trautmann","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.jaut.2023.103131_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-019-1325-x","article-title":"TOX transcriptionally and epigenetically programs CD8+ T cell exhaustion","volume":"571","author":"Khan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2023.103131_bib30","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.4049\/jimmunol.159.3.1418","article-title":"Suppression of concanavalin A-induced hepatitis in IFN-gamma(-\/-) mice, but not in TNF-alpha(-\/-) mice: role for IFN-gamma in activating apoptosis of hepatocytes","volume":"159","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1074-7613(04)00050-0","article-title":"B7-H1 determines accumulation and deletion of intrahepatic CD8+ T lymphocytes","volume":"20","author":"Dong","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2023.103131_bib32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/rheumatology\/kez248","article-title":"A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role","volume":"59","author":"Kamiya","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103131_bib33","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s12276-021-00568-0","article-title":"Transcriptional regulatory network for the establishment of CD8+ T cell exhaustion","volume":"53","author":"Seo","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jaut.2023.103131_bib34","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.3389\/fimmu.2022.866179","article-title":"Exhausted PD-1+ TOX+ CD8+ T cells arise only in long-term experimental trypanosoma cruzi infection","volume":"13","author":"G\u00e1lvez","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib35","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jaut.2023.103131_bib36","first-page":"1861","article-title":"Expanded circulating peripheral helper T cells in systemic lupus erythematosus: association with disease activity and B cell differentiation","volume":"58","author":"Makiyama","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103131_bib37","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1093\/rheumatology\/kez228","article-title":"PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus","volume":"58","author":"Lin","year":"2019","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103131_bib38","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1002\/art.27625","article-title":"Definitive engagement of cytotoxic CD8 T cells in C protein-induced myositis, a murine model of polymyositis","volume":"62","author":"Sugihara","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2023.103131_bib39","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1002\/ar.23834","article-title":"Immunological behavior analysis of muscle cells under IFN-\u03b3 stimulation in vitro and in vivo","volume":"301","author":"Ding","year":"2018","journal-title":"Anat. Rec."},{"key":"10.1016\/j.jaut.2023.103131_bib40","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.aae0477","article-title":"Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity","volume":"353","author":"Dorand","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.jaut.2023.103131_bib41","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1073\/pnas.0307606100","article-title":"Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity","volume":"101","author":"Fu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2023.103131_bib42","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1002\/art.24689","article-title":"Therapeutic effects of interleukin-6 blockade in a murine model of polymyositis that does not require interleukin-17A","volume":"60","author":"Okiyama","year":"2009","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2023.103131_bib43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41590-021-01125-7","article-title":"PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity","volume":"23","author":"Sugiura","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib44","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.molcel.2019.12.012","article-title":"PD-1 imposes qualitative control of cellular transcriptomes in response to T cell activation","volume":"77","author":"Shimizu","year":"2020","journal-title":"Mol Cell"},{"key":"10.1016\/j.jaut.2023.103131_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg0675","article-title":"Clonally expanded, thyrotoxic effector CD8+ T cells driven by IL-21 contribute to checkpoint inhibitor thyroiditis","volume":"15","author":"Lechner","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jaut.2023.103131_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2102164118","article-title":"Computational design of a synthetic PD-1 agonist","volume":"118","author":"Bryan","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2023.103131_bib47","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.152468","article-title":"Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors","volume":"6","author":"Curnock","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2023.103131_bib48","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41551-019-0360-0","article-title":"Depletion of PD-1-positive cells ameliorates autoimmune disease","volume":"3","author":"Zhao","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jaut.2023.103131_bib49","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1056\/NEJMoa2209856","article-title":"A phase 2 trial of peresolimab for adults with rheumatoid arthritis","volume":"388","author":"Tuttle","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103131_bib50","doi-asserted-by":"crossref","first-page":"13866","DOI":"10.1073\/pnas.231486598","article-title":"PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine","volume":"98","author":"Okazaki","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaut.2023.103131_bib51","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/art.38270","article-title":"Predictors of clinical improvement in rituximab-treated refractory adult and juvenile dermatomyositis and adult polymyositis","volume":"66","author":"Aggarwal","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103131_bib52","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/ni.2705","article-title":"Tissue-resident macrophages","volume":"14","author":"Davies","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2023.103131_bib53","first-page":"886","volume":"41","author":"Schenkel","year":"2014","journal-title":"Tissue-resident memory T cells, Immunity"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123001403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:31:37Z","timestamp":1760257897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123001403"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":53,"alternative-id":["S0896841123001403"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103131","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenicity of functionally activated PD-1+CD8+ cells and counterattacks by muscular PD-L1 through IFN\u03b3 in myositis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103131"}}